118 - Excellent Relapse-Free and Overall Survival in Pre-HCT Next-Generation Sequencing (NGS-MRD) Negative B-ALL Patients with or without TBI-Based Conditioning: Outcome of the Observational Arm of the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) ONC1701 Endrad Study

Hisham Abdel‐Azim ,Heather E Stefanski,Jeffrey S Huo,Troy C Quigg,Jemily Malvar,Elizabeth Gourdine,Biljana Horn,Rachel Phelan,Joseph H Chewning,Dana Salzberg,Shalini Shenoy,Benjamin Oshrine,Amy K Keating,Rabi Hanna,Neena Kapoor,Jason Law,Barbara Bambach,Christine S Higham ,Kris Michael Mahadeo ,Nahal Lalefar ,Jodi Skiles ,Leslie Lehmann ,Emi Caywood ,Niketa C Shah ,Ibrahim Aliyu ,Ulrich Duffner ,Lisa Madden ,Michael A Pulsipher

doi:10.1016/s2666-6367(23)00187-2

118 - Excellent Relapse-Free and Overall Survival in Pre-HCT Next-Generation Sequencing (NGS-MRD) Negative B-ALL Patients with or without TBI-Based Conditioning: Outcome of the Observational Arm of the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) ONC1701 Endrad Study

Hisham Abdel‐Azim , Heather E Stefanski + Show 26 more

https://doi.org/10.1016/s2666-6367(23)00187-2

Copy DOI

Journal: Biology of Blood and Marrow Transplantation	Publication Date: Feb 1, 2023
Citations: 2

#TBI-Based Conditioning #Excellent Survival + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

118 - Excellent Relapse-Free and Overall Survival in Pre-HCT Next-Generation Sequencing (NGS-MRD) Negative B-ALL Patients with or without TBI-Based Conditioning: Outcome of the Observational Arm of the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC) ONC1701 Endrad Study

Full Text